drugset / Trial / NCT05945797

Effects of Dexamethasone on Common Bile Duct Cannulation Time

NCT05945797 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

The main aim of this clinical trial is to evaluate the effects of dexamethasone on common bile duct cannulation time during endoscopic retrograde cholangiopancreatography (ERCP) in patients with biliary pathologies. The study will also study the effects of dexamethasone on total procedure time and total fluoroscopy time during ERCP. Participants will be divided into two groups, treatment group and placebo group. Patients in treatment group will receive dexamethasone and those in placebo group will be given normal saline before undergoing ERCP. The results in both groups will be compared to determine the effects of dexamethasone.

Timeline

Start
2023-08-01
Primary completion
2024-04-12
Completion
2024-05-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 4 mg —